{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:33:29Z","timestamp":1772940809740,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:00:00Z","timestamp":1424995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00431-015-2505-9","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T04:59:47Z","timestamp":1424926787000},"page":"707-714","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience"],"prefix":"10.1007","volume":"174","author":[{"given":"Svetlana","family":"Kostjukovits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liisa","family":"Kalliokoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisu","family":"Antila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Korppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,27]]},"reference":[{"issue":"3","key":"2505_CR1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2249.2002.02002.x","volume":"130","author":"PD Arkwright","year":"2002","unstructured":"Arkwright PD, McDermott MF, Houten SM, Frenkel J, Waterham HR, Aganna E et al (2002) Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept. Clin Exp Immunol 130(3):484\u2013488","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2505_CR2","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","volume":"128","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, SOFREMIP (Soci\u00e9t\u00e9 Francophone pour la Rhumatologie et les Maladies Inflammatoires en P\u00e9diatrie), CRI (Club Rhumatismes et Inflammations) et al (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128(1):e152\u2013e159","journal-title":"Pediatrics"},{"issue":"8","key":"2505_CR3","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/gutjnl-2013-306555","volume":"63","author":"AM Bianco","year":"2014","unstructured":"Bianco AM, Girardelli M, Vozzi D, Crovella S, Kleiner G, Marcuzzi A (2014) Mevalonate kinase deficiency and IBD: shared genetic background. Gut 63(8):1367\u20131368","journal-title":"Gut"},{"issue":"Suppl 11","key":"2505_CR4","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1002\/art.38497","volume":"66","author":"C Biggs","year":"2014","unstructured":"Biggs C, Dedeoglu F (2014) A81: spectrum of mevalonate kinase deficiency: is colitis more common than we think? Arthritis Rheum 66(Suppl 11):S114","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2505_CR5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1136\/ard.2011.149922","volume":"70","author":"EJ Bodar","year":"2011","unstructured":"Bodar EJ, Kuijk LM, Drenth JP, van der Meer JW, Simon A, Frenkel J (2011) On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 70(12):2155\u20132158","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2505_CR6","first-page":"695","volume":"27","author":"L Breda","year":"2009","unstructured":"Breda L, Nozzi M, Di Marzio D, De Sanctis S, Gattorno M, Chiarelli F (2009) Recurrent pericarditis in hyper-IgD syndrome. Clin Exp Rheumatol 27(4):695","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"2505_CR7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s10067-014-2523-4","volume":"33","author":"R Campanilho-Marques","year":"2014","unstructured":"Campanilho-Marques R, Brogan PA (2014) Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature. Clin Rheumatol 33(11):1681\u20131684","journal-title":"Clin Rheumatol"},{"key":"2505_CR8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1750-1172-8-196","volume":"8","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Vitale A, Magnotti F, Lucherini OM, Caso F, Frediani B et al (2013) Weekly oral alendronate in mevalonate kinase deficiency. Orphanet J Rare Dis 8:196","journal-title":"Orphanet J Rare Dis"},{"issue":"5053","key":"2505_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1373520","volume":"256","author":"DP Cerretti","year":"1992","unstructured":"Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA et al (1992) Molecular cloning of the interleukin-1 beta converting enzyme. Science 256(5053):97\u2013100","journal-title":"Science"},{"issue":"4","key":"2505_CR10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","volume":"9","author":"L Cuisset","year":"2001","unstructured":"Cuisset L, Drenth JP, Simon A, Vincent MF, van der Velde VS, van der Meer JW et al (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9(4):260\u2013266","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"2505_CR11","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s10067-006-0501-1","volume":"26","author":"E Demirkaya","year":"2007","unstructured":"Demirkaya E, Caglar MK, Waterham HR, Topalo\u011flu R, Ozen S (2007) A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26(10):1757\u20131759","journal-title":"Clin Rheumatol"},{"key":"2505_CR12","unstructured":"European Medicines Agency. Ilaris, canakinumab: summary of product characteristics [online]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001109\/WC500031680.pdf (Assessed 30th May 2014)."},{"key":"2505_CR13","unstructured":"European Medicines Agency. Kineret, anakinra: summary of product characteristics [online]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000363\/WC500042310.pdf (Assessed 30th May 2014)."},{"key":"2505_CR14","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.10550","volume":"46","author":"J Frenkel","year":"2002","unstructured":"Frenkel J, Rijkers GT, Mandey SH, Buurman SW, Houten SM, Wanders RJ et al (2002) Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 46:2794\u20132803","journal-title":"Arthritis Rheum"},{"issue":"10","key":"2505_CR15","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","volume":"51","author":"C Galeotti","year":"2012","unstructured":"Galeotti C, Meinzer U, Quartier P, Rossi-Semerano L, Bader-Meunier B, Pillet P et al (2012) Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatology (Oxford) 51(10):1855\u20131859","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2505_CR16","first-page":"641","volume":"54","author":"P Gen\u00e7p\u0131nar","year":"2012","unstructured":"Gen\u00e7p\u0131nar P, Makay BB, Gattorno M, Caroli F, \u00dcnsal E (2012) Mevalonate kinase deficiency (hyper IgD syndrome with periodic fever)\u2014different faces with separate treatments: two cases and review of the literature. Turk J Pediatr 54(6):641\u2013644","journal-title":"Turk J Pediatr"},{"issue":"4","key":"2505_CR17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/annrheumdis-2011-155143","volume":"71","author":"A G\u00fcl","year":"2012","unstructured":"G\u00fcl A, Tugal-Tutkun I, Dinarello CA, Reznikov L, Esen BA, Mirza A et al (2012) Interleukin-1\u03b2-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet\u2019s disease: an open-label pilot study. Ann Rheum Dis 71(4):563\u2013566","journal-title":"Ann Rheum Dis"},{"key":"2505_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","volume":"1","author":"D Haas","year":"2006","unstructured":"Haas D, Hoffmann GF (2006) Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 1:13","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2505_CR19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","volume":"157","author":"PJ Hashkes","year":"2012","unstructured":"Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G et al (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 157(8):533\u2013541","journal-title":"Ann Intern Med"},{"issue":"10","key":"2505_CR20","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.clinthera.2012.09.009","volume":"34","author":"HM Hoffman","year":"2012","unstructured":"Hoffman HM, Throne ML, Amar NJ, Cartwright RC, Kivitz AJ, Soo Y et al (2012) Long-term efficacy and safety profile of rilonacept in the treatment of cryopyrin-associated periodic syndromes: results of a 72-week open-label extension study. Clin Ther 34(10):2091\u20132103","journal-title":"Clin Ther"},{"issue":"5","key":"2505_CR21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1542\/peds.91.5.915","volume":"91","author":"GF Hoffmann","year":"1993","unstructured":"Hoffmann GF, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson KM et al (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91(5):915\u2013921","journal-title":"Pediatrics"},{"issue":"2","key":"2505_CR22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","volume":"22","author":"SM Houten","year":"1999","unstructured":"Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, Frenkel J et al (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22(2):175\u2013177","journal-title":"Nat Genet"},{"issue":"1","key":"2505_CR23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2010.01974.x","volume":"100","author":"M Korppi","year":"2011","unstructured":"Korppi M, Van Gijn ME, Antila K (2011) Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report. Acta Paediatr 100(1):21\u201325","journal-title":"Acta Paediatr"},{"key":"2505_CR24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1546-0096-7-14","volume":"7","author":"CL Kraus","year":"2009","unstructured":"Kraus CL, Culican SM (2009) Nummular keratopathy in a patient with hyper-IgD syndrome. Pediatr Rheumatol Online J 7:14","journal-title":"Pediatr Rheumatol Online J"},{"key":"2505_CR25","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.molimm.2007.12.008","volume":"45","author":"LM Kuijk","year":"2008","unstructured":"Kuijk LM, Mandey SH, Schellens I, Waterham HR, Rijkers GT, Coffer PJ et al (2008) Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol 45:2158\u20132165","journal-title":"Mol Immunol"},{"issue":"6","key":"2505_CR26","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.21901","volume":"54","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann HJ, Goodman HJ, Andrews PA, Gallagher H, Marsh J, Breuer S et al (2006) AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases. Arthritis Rheum 54(6):2010\u20132014","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2505_CR27","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1542\/peds.2012-3344","volume":"132","author":"M Levy","year":"2013","unstructured":"Levy M, Arion A, Berrebi D, Cuisset L, Jeanne-Pasquier C, Bader-Meunier B et al (2013) Severe early-onset colitis revealing mevalonate kinase deficiency. Pediatrics 132(3):e779\u2013e783","journal-title":"Pediatrics"},{"issue":"6","key":"2505_CR28","first-page":"865","volume":"32","author":"G Li Cavoli","year":"2012","unstructured":"Li Cavoli G, Passantino D, Tortorici C, Bono L, Ferrantelli A, Giammarresi C et al (2012) Renal amyloidosis due to hyper-IgD syndrome. Nefrologia 32(6):865\u2013866","journal-title":"Nefrologia"},{"key":"2505_CR29","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SH Mandey","year":"2006","unstructured":"Mandey SH, Kuijk LM, Frenkel J, Waterham HR (2006) A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 54:3690\u20133695","journal-title":"Arthritis Rheum"},{"key":"2505_CR30","doi-asserted-by":"crossref","unstructured":"Mansouri B, Richards L, Menter A (2014) Treatment of two patients with generalised pustular psoriasis with the interleukin-1\u03b2 inhibitor gevokizumab. Br J Dermatol. doi: 10.1111\/bjd.13614","DOI":"10.1111\/bjd.13614"},{"issue":"6","key":"2505_CR31","first-page":"791","volume":"22","author":"F Marchetti","year":"2004","unstructured":"Marchetti F, Barbi E, Tommasini A, Oretti C, Ventura A (2004) Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol 22(6):791\u2013792","journal-title":"Clin Exp Rheumatol"},{"key":"2505_CR32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417\u2013426","journal-title":"Mol Cell"},{"key":"2505_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229\u2013265","journal-title":"Annu Rev Immunol"},{"key":"2505_CR34","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1542\/peds.2006-2015","volume":"119","author":"M Nevyjel","year":"2007","unstructured":"Nevyjel M, Pontillo A, Calligaris L, Tommasini A, D\u2019Osualdo A, Waterham HR et al (2007) Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Pediatrics 119:e523\u2013e527","journal-title":"Pediatrics"},{"issue":"3","key":"2505_CR35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/ecn.2009.0163","volume":"20","author":"S Normand","year":"2009","unstructured":"Normand S, Massonnet B, Delwail A, Favot L, Cuisset L, Grateau G et al (2009) Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation. Eur Cytokine Netw 20(3):101\u2013107","journal-title":"Eur Cytokine Netw"},{"issue":"9","key":"2505_CR36","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/art.20490","volume":"50","author":"L Obici","year":"2004","unstructured":"Obici L, Manno C, Muda AO, Picco P, D\u2019Osualdo A, Palladini G et al (2004) First report of systemic reactive (AA) amyloidosis in a patient with the hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheum 50(9):2966\u20132969","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2505_CR37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mlc.2003.31","volume":"141","author":"AS Pappu","year":"2003","unstructured":"Pappu AS, Bacon SP, Illingworth DR (2003) Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia. J Lab Clin Med 141(4):250\u2013256","journal-title":"J Lab Clin Med"},{"key":"2505_CR38","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ejhg.2010.9","volume":"18","author":"A Pontillo","year":"2010","unstructured":"Pontillo A, Paoluzzi E, Crovella S (2010) The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency. Eur J Hum Genet 18:844\u2013847","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2505_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-006-0164-x","volume":"27","author":"D Rigante","year":"2006","unstructured":"Rigante D, Ansuini V, Bertoni B, Pugliese AL, Avallone L, Federico G et al (2006) Treatment with anakinra in the hyperimmunoglobulinemia D\/periodic fever syndrome. Rheumatol Int 27(1):97\u2013100","journal-title":"Rheumatol Int"},{"issue":"2","key":"2505_CR40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.gene.2014.03.031","volume":"542","author":"JA Santos","year":"2014","unstructured":"Santos JA, Ar\u00f3stegui JI, Brito MJ, Neves C, Conde M (2014) Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype. Gene 542(2):217\u2013220","journal-title":"Gene"},{"issue":"2","key":"2505_CR41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.RHU.0000442576.41537.de","volume":"20","author":"HM Shendi","year":"2014","unstructured":"Shendi HM, Devlin LA, Edgar JD (2014) Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome. J Clin Rheumatol 20(2):103\u2013105","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"2505_CR42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00296-009-1322-8","volume":"32","author":"HM Shendi","year":"2012","unstructured":"Shendi HM, Walsh D, Edgar JD (2012) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int 32(1):249\u2013251","journal-title":"Rheumatol Int"},{"issue":"3","key":"2505_CR43","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1053\/j.ajkd.2006.05.027","volume":"48","author":"R Siewert","year":"2006","unstructured":"Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48(3):e41\u2013e45","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2505_CR44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","volume":"75","author":"A Simon","year":"2004","unstructured":"Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF et al (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75(5):476\u2013483","journal-title":"Clin Pharmacol Ther"},{"key":"2505_CR45","doi-asserted-by":"crossref","unstructured":"Stoffels M, Jongekrijg J, Remijn T, Kok N, van der Meer JW, Simon A (2014) TLR2\/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome. Rheumatology (Oxford) 54(2):363\u2013368","DOI":"10.1093\/rheumatology\/keu341"},{"issue":"9","key":"2505_CR46","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","volume":"48","author":"K Takada","year":"2003","unstructured":"Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48(9):2645\u20132651","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2505_CR47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N Haar Ter","year":"2013","unstructured":"Ter Haar N, Lachmann H, \u00d6zen S, Woo P, Uziel Y, Modesto C, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever\/Eurotraps Projects et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 72(5):678\u2013685","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2505_CR48","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1542\/peds.2012-1372","volume":"133","author":"VS Thors","year":"2014","unstructured":"Thors VS, Vastert SJ, Wulffraat N, van Royen A, Frenkel J, de Sain-van der Velden M et al (2014) Periodic fever in MVK deficiency: a patient initially diagnosed with incomplete Kawasaki disease. Pediatrics 133(2):e461\u2013e465","journal-title":"Pediatrics"},{"issue":"10","key":"2505_CR49","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10067-008-0911-3","volume":"27","author":"R Topalo\u011flu","year":"2008","unstructured":"Topalo\u011flu R, Ayaz NA, Waterham HR, Y\u00fcce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27(10):1317\u20131320","journal-title":"Clin Rheumatol"},{"issue":"4","key":"2505_CR50","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.3390\/ijms15046843","volume":"15","author":"PM Tricarico","year":"2014","unstructured":"Tricarico PM, Kleiner G, Valencic E, Campisciano G, Girardelli M, Crovella S et al (2014) Block of the mevalonate pathway triggers oxidative and inflammatory molecular mechanisms modulated by exogenous isoprenoid compounds. Int J Mol Sci 15(4):6843\u20136856","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2505_CR51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","volume":"87","author":"JC Hilst van der","year":"2008","unstructured":"van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, International HIDS Study Group et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87(6):301\u2013310","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2505_CR52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13506120500106982","volume":"12","author":"JC Hilst van der","year":"2005","unstructured":"van der Hilst JC, Drenth JP, Bodar EJ, Bijzet J, van der Meer JW, Simon A, International HIDS Study Group (2005) Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in hyper-IgD syndrome. Amyloid 12(2):115\u2013119","journal-title":"Amyloid"},{"key":"2505_CR53","first-page":"936890","volume":"2014","author":"ML Linstow von","year":"2014","unstructured":"von Linstow ML, Rosenfeldt V (2014) Neonatal hepatitis as first manifestation of hyperimmunoglobulinemia D syndrome. Case Rep Pediatr 2014:936890","journal-title":"Case Rep Pediatr"},{"issue":"1","key":"2505_CR54","first-page":"70","volume":"7","author":"S Yel","year":"2013","unstructured":"Yel S, Gunduz Z, Bastug F, Dusunsel R, Dursun I, Poyrazoglu H et al (2013) Amyloidosis in a child with hyperimmunoglobulinemia D syndrome. Iran J Kidney Dis 7(1):70\u201372","journal-title":"Iran J Kidney Dis"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2505-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-015-2505-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2505-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T20:24:52Z","timestamp":1651350292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-015-2505-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1007\/s00431-015-2505-9","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,27]]}}}